Aligos Therapeutics ALGS
NASDAQ ALGS
$5.13 +0.10 (+1.99%)
As of: Oct 21, 2026 · 11:26 AM EDT

Aligos Therapeutics (ALGS) FCF Margin (2019 - 2026)

Updated

Aligos Therapeutics' FCF Margin was -817.24% in Q1 2026, up 5905.91 percentage points from -6723.15% a year earlier and up 12049.62 percentage points from the prior quarter.

Analysis

Aligos Therapeutics (ALGS) FCF Margin (2019 - 2026) Analysis & Trends

For FY2025, FCF Margin at Aligos Therapeutics came in at -3774.15%, down 1534.52 percentage points from FY2024.

  • FCF Margin has now declined for three consecutive years, with a four-year change of -1100.28 percentage points (FY2021 to FY2025).
  • In earlier years, FCF Margin was -2239.63% in FY2024 (-1393.45 pp), -846.18% in FY2023 (-268.54 pp), -577.64% in FY2022 (+2096.23 pp) and -2673.87% in FY2021.
  • The Q1 2026 figure marks the highest quarterly FCF Margin since Q2 2023.
  • Compared with a year earlier, FCF Margin was higher in two of the last eight quarters, with an average year-over-year change of -1613.70 percentage points.
  • The best year-over-year quarter for FCF Margin over five years was Q4 2022 (a gain of 9827.02 percentage points); the worst was Q4 2025 (a drop of 9830.07 percentage points).
  • Per Business Quant data, ALGS's FCF Margin in the three quarters before Q1 2026 was -12866.86% (Q4 2025), -3285.43% (Q3 2025) and -1606.63% (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn 33.76%
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn 28.82%
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn 18.33%
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn 26.96%
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn 38.60%
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn 6.55%
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn 34.70%
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn 44.00%
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn 2.01%
10 Aligos Therapeutics 53.51 Mn -274.90 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -817.24%
Dec 31, 2025 -12,866.86%
Sep 30, 2025 -3,285.43%
Jun 30, 2025 -1,606.63%
Mar 31, 2025 -6,723.15%
Dec 31, 2024 -3,036.80%
Sep 30, 2024 -1,608.08%
Jun 30, 2024 -1,837.23%
Mar 31, 2024 -3,277.52%
Dec 31, 2023 -1,127.82%
Sep 30, 2023 -944.10%
Jun 30, 2023 -317.09%
Mar 31, 2023 -866.98%
Dec 31, 2022 -477.07%
Sep 30, 2022 -417.44%
Jun 30, 2022 -686.95%
Mar 31, 2022 -814.82%
Dec 31, 2021 -10,304.09%
Sep 30, 2021 -1,656.80%
Jun 30, 2021 -1,499.68%
API Access

Aligos Therapeutics FCF Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=fcf-margin&ticker=ALGS&period=max&api_key=YOUR_API_KEY